Public Policy Priorities

Advocating for a Greater Life Science Future

 
Access to Water
Access to Water

California is experiencing prolonged drought conditions, and mandatory water cutbacks have been implemented throughout the state. Biocom is in regular contact with stakeholders most affected by this crisis, including the agencies who supply Southern California’s water. Biocom is adamant in encouraging city officials to publicize water legislation beneficial to the life science industry such as the Guaranteed Water for Industry Program, and encourages politicians to consider alternative measures before implementing mandatory shutoffs to businesses, and continue to support nontraditional water resources.Learn More

Agricultural and Industrial Biotech
Agricultural and Industrial Biotech

Biotechnology has revolutionized how we feed and fuel the world and is a driver of some of the most exciting advancements in agriculture and energy of the century. By supporting policies that promote the development and production of advanced biofuels, renewable chemicals and biobased products, and communicate science-based information to consumers relevant to health, safety, and nutrition, Biocom gives members a powerful voice in Washington, D.C. and an environment which supports agricultural and industrial biotechnology innovation.Learn More

Biomedical Research Funding
Biomedical Research Funding

Federal investment in biomedical research is essential to the development of new drugs, vaccines, and technologies by supporting breakthrough research happening across the nation and especially in California. In Fiscal Year 2016, funding from the National Institutes of Health (NIH) supported over 7,500 grants in California alone, helping universities, research institutes and small companies turn ideas into innovative products. Biocom’s policy team is relentless working to ensure the continuity of funding for the NIH as well as biodefense and pandemic research programs. Learn More

Climate Action Plan
Climate Action Plan

Biocom’s policy team works hard to ensure that San Diego’s life science cluster works in an environment that reflects its work to create a more sustainable future. In December 2015, Biocom supported San Diego City Council’s approval of the city’s Climate Action Plan (CAP) to reduce greenhouse gas emissions by 40% below 1990 levels by 2030 in accordance with state law and will continue to support the inclusion of cost-benefit analysis of any regulations that are implemented during the next phase of the plan.Learn More

Digital Health and Genomics
Digital Health and Genomics

Digital health has revolutionized our health care system by introducing technologies that allow for more efficient, targeted, and patient-centered approaches to the diagnostic and treatment of disease and delivery of care. As a result, Biocom staunchly supports policies that streamline the regulation and expand the reimbursement of digital apps and devices, remote patient monitoring technologies, and genomics products, as well as educational efforts that help patients, providers, and caregivers better understand the benefits and usage of these life-changing products. Learn More

FDA Regulatory Policy
FDA Regulatory Policy

Biocom is dedicated to improving the drug and device review and approval process, communication between industry and the Food and Drug Administration (FDA), and transparency and accountability within the agency. From advocating for continued funding for the agency and supporting industry-friendly legislation, to engaging on important regulatory matters and keeping members up-to-date, Biocom works with Congress, the FDA, and industry to create an environment that helps bring new treatments and cures to patients faster. Learn More

Intellectual Property and Patent Law
Intellectual Property and Patent Law

Intellectual property is the lifeblood of the life science industry. Patents are so important to America’s prosperity that they have been enshrined in our Constitution as fundamental rights. Those rights have provided the foundation for a culture of innovation and entrepreneurship that has been an essential driver of our exceptional economic growth and global leadership. Biocom has vehemently opposed and will continue to oppose legislation that undermines those rights in any way, while supporting initiatives in Congress and at the Patent and Trademark Office (USPTO) that promote life science innovation. Learn More

Permits and Inspections
Permits and Inspections

Biocom supports efforts to make city and county permitting processes transparent and efficient. Inconsistent standards for inspections have been an ongoing issue for our members, and one that we have been working on with government staff for many years. We appreciate efforts to ensure inspections are done consistently and in collaboration with businesses.Learn More

Prime Industrial Land
Prime Industrial Land

Biocom prioritizes the preservation of Prime Industrial Lands (PIL) for manufacturing, research and development, and distribution to ensure member companies operate in environments conducive to regional long-term economic stability and industry growth. Biocom opposes discretionary approvals that remove PIL sites from the PIL land map and supports community plan updates that preserve Prime Industrial Lands, and prevent incompatible land uses by voting against collocated projects.Learn More

Reimbursement and Patient Access To Care
Reimbursement and Patient Access To Care

Biocom is committed to ensuring that patients have access to the care they need and supports reimbursement policies that provide appropriate and inclusive coverage, coding, and payment for biopharmaceutical, medical device, diagnostic, and genomics products. Biocom has strongly opposed proposals that would cut reimbursement to physicians under Medicare Part B, impose rebates and price controls to Medicare Part D, and limit the availability of products through restrictive formularies, step therapy, and increased cost-sharing such as specialty tiers and high deductibles. Learn More

SANDAG 2050 Regional Plan
SANDAG 2050 Regional Plan

An efficient transportation system is an important part of business attraction and retention. In October 2015, the board of the San Diego regional planning agency voted unanimously to approve a spending plan that will fund transportation projects for the next 35 years. The plan includes transit and freeway expansion, changing land use patterns, plans for sustainability, and economic benefits. SANDAG is considering a ballot measure that would implement the Regional Plan, which would ask voters to increase our local sales tax by up to one-half center. Learn More

STEM Education and Workforce
STEM Education and Workforce

Biocom supports science, technology, engineering, and math (STEM) education in the United States to inspire the industry leaders of tomorrow and equip educators with the tools needed to prepare them. Through the Biocom Institute and dozens of annual programs, Biocom promotes the life sciences by creating opportunities for STEM students, teachers, scientists, and life science companies to work together and grow a diverse community of life science professionals. Biocom also supports immigration policies that provide American employers with greater access to the world’s best talents. Learn More

Storm Water Channel Maintenance
Storm Water Channel Maintenance

Most recently in January 2016, flooding in Sorrento Valley during storm events threatened many businesses, especially along Roselle Street. There are several Biocom member companies located on Roselle Street, and many more areas up and down California. Floods like these cause physical damage to businesses and result in lost revenue when workers are evacuated, and Biocom works hard to ensure the city protects the facilities that are important to life science innovation. Learn More

Taxes
Taxes

Biocom is advocating for tax policies that promote research, innovation, and advanced manufacturing. A lower corporate tax code, territorial tax system, and incentives for high-risk industries would ensure that U.S. companies are successful at home and competitive abroad. Biocom also supports keeping the research and development tax credit permanent, repealing the medical device tax, and extending the orphan drug tax credit and renewable energy tax incentives. Learn More

 

Public Policy Newsletter

Members: Sign up to receive updates regarding the most important recent policy news.